« Return to News | Drug Sponsors

AstraZeneca, IMS Health team up to use real-world evidence

Wednesday, January 11, 2012 03:40 PM

AstraZeneca has entered into a three-year collaboration agreement with IMS Health, a leading provider of healthcare information, services and technology, to further the use of real-world evidence based on observational and retrospective studies.

The pair hopes the information will provide a deeper insight into how medicines already on the market are working on real-world settings across Europe, illuminating unmet needs in the current standard of care and treatment patterns across a number of therapeutic areas, with an emphasis on chronic illnesses.

"Our collaboration with IMS is a key milestone in our commitment to understand the impact of our medicines in the real world, beyond what we see in controlled clinical trials,” said Martin Mackay, president of R&D for AstraZeneca. “This insight will help us and healthcare decision-makers to improve the treatment of disease and ensure effective use of medicines to minimize the burden on individuals and healthcare budgets."

The partnership will give AstraZeneca access to pre-existing anonymized electronic health record, which includes clinical outcome, economic and treatment pattern data. The companies also plan to jointly develop a customized research and data analysis platform.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.